The US Food and Drug Administration (FDA) has approved Medtronic’s Altaviva device, intended for the treatment of urge ...
MDT gains FDA approval for its Altaviva device, a minimally invasive bladder control therapy with long-lasting benefits.
Inserted near the ankle in a minimally invasive procedure, the device generates low-level electronic impulses that stimulate ...
Analysts said Altaviva is an attractive option compared to rival products, informing their belief that Medtronic can ...
Medtronic has received FDA approval for a new implant aimed at improving bladder control, with a small device placed near the ...
Medtronic's Altaviva wins FDA approval as a minimally invasive implant for urge urinary incontinence, offering long-lasting ...
Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ device. The minimally ...
Timed release of therapeutic molecules from a soft nanofiber-hydrogel implant supports nerve regrowth and circuit repair ...